These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor. Ravi M; Beljorie M; El Masry K J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458 [No Abstract] [Full Text] [Related]
6. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women. Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172 [TBL] [Abstract][Full Text] [Related]
7. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study. Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753 [TBL] [Abstract][Full Text] [Related]
8. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin. Asakura H; Fukami T; Kurashina R; Tateyama N; Doi D; Takeshita T Gynecol Obstet Invest; 2009; 68(1):1-8. PubMed ID: 19321961 [TBL] [Abstract][Full Text] [Related]
9. Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth. Amabebe E; Chapman DR; Stern VL; Stafford G; Anumba DOC J Reprod Immunol; 2018 Apr; 126():1-10. PubMed ID: 29367099 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic low-risk women. Jwala S; Tran TL; Terenna C; McGregor A; Andrel J; Leiby BE; Baxter JK; Berghella V Acta Obstet Gynecol Scand; 2016 Aug; 95(8):948-55. PubMed ID: 27100022 [TBL] [Abstract][Full Text] [Related]
11. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Leeson SC; Maresh MJ; Martindale EA; Mahmood T; Muotune A; Hawkes N; Baldwin KJ Br J Obstet Gynaecol; 1996 Jan; 103(1):48-53. PubMed ID: 8608098 [TBL] [Abstract][Full Text] [Related]
12. [Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor]. García Alonso A; Ayala Méndez JA; Izquierdo Puente JC; Jiménez Solís G; Sánchez Martínez M Ginecol Obstet Mex; 1999 Jan; 67():23-8. PubMed ID: 10085606 [TBL] [Abstract][Full Text] [Related]
13. A comparison of prevaginal and postvaginal manipulation fetal fibronectin. Turitz AL; Ackerman CM; Johnson DL; Bank TC; Duong JK; Lee SM; Gyamfi-Bannerman C Am J Obstet Gynecol; 2016 May; 214(5):646.e1-6. PubMed ID: 26924744 [TBL] [Abstract][Full Text] [Related]
14. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery. Ng VWY; Seto MTY; Lewis H; Cheung KW BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314 [TBL] [Abstract][Full Text] [Related]
15. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation. Parker J; Bell R; Brennecke S Aust N Z J Obstet Gynaecol; 1995 Aug; 35(3):257-61. PubMed ID: 8546638 [TBL] [Abstract][Full Text] [Related]
16. The Biomarkers for Preterm Birth Study-A prospective observational study comparing the impact of vaginal biomarkers on clinical practice when used in women with symptoms of preterm labor. Dawes LK; Prentice LR; Huang Y; Groom KM Acta Obstet Gynecol Scand; 2020 Feb; 99(2):249-258. PubMed ID: 31519040 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Abbott DS; Radford SK; Seed PT; Tribe RM; Shennan AH Am J Obstet Gynecol; 2013 Feb; 208(2):122.e1-6. PubMed ID: 23164760 [TBL] [Abstract][Full Text] [Related]
18. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. Lockwood CJ; Senyei AE; Dische MR; Casal D; Shah KD; Thung SN; Jones L; Deligdisch L; Garite TJ N Engl J Med; 1991 Sep; 325(10):669-74. PubMed ID: 1870640 [TBL] [Abstract][Full Text] [Related]
19. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. Lockwood CJ; Wein R; Lapinski R; Casal D; Berkowitz G; Alvarez M; Berkowitz RL Am J Obstet Gynecol; 1993 Oct; 169(4):798-804. PubMed ID: 8238134 [TBL] [Abstract][Full Text] [Related]
20. [Quantitative determination of fetal fibronectin in cervical smears: a new marker for evaluating the risk of premature labor]. Hampl M; Friese K; Hofmann I; Melchert F Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):685-90. PubMed ID: 7851710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]